Insider Trading History of Rust Christopher J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Rust Christopher J since 2011. The trader's CIK number is 1316575. At the time of the last reporting, Rust Christopher J was the 10% Owner of Oncomed Pharmaceuticals Inc. (stock ticker symbol OMED). Also see all insider trading activities at Oncomed Pharmaceuticals Inc.

Note that in the past Rust Christopher J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Imperva Inc (IMPV) by Rust Christopher J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 IMPV 152,919 $2,752,542 0 $0 0 $0

Yearly summary of insider trading at Guidewire Software, Inc. (GWRE) by Rust Christopher J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 GWRE 0 $0 3,249,173 $91,865,197 0 $0

Yearly summary of insider trading at Oncomed Pharmaceuticals Inc (OMED) by Rust Christopher J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 OMED 158,823 $2,699,991 0 $0 0 $0


Insider trading activities at 3 companies by Rust Christopher J:

1. Imperva Inc (IMPV)

2. Guidewire Software, Inc. (GWRE)

3. Oncomed Pharmaceuticals Inc (OMED)

Table 1. Insider trading of Imperva Inc (IMPV) by Rust Christopher J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-11-09 IMPV Buy 152,919 18.00 2,752,542

Table 2. Insider trading of Guidewire Software, Inc. (GWRE) by Rust Christopher J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-09-17 GWRE Sale 20,411 31.30 638,905
2012-09-18 GWRE Sale 4,780 31.13 148,801
2012-04-24 GWRE Sale 3,223,982 28.25 91,077,491

Table 3. Insider trading of Oncomed Pharmaceuticals Inc (OMED) by Rust Christopher J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-07-23 OMED Buy 158,823 17.00 2,699,991

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rust Christopher J (10% Owner of Oncomed Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.